US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. August 06, 2020

    Pharmacies Can't Dodge Ohio Opioid MDL's 2021 Bellwether

    The Ohio federal judge overseeing opioid multidistrict litigation has refused to toss two Ohio counties' bellwether cases against pharmacies, allowing their public nuisance claims over the dispensing and distribution of opioids to move forward.

  2. August 03, 2020

    Top Product Liability Cases Of 2020: Midyear Review

    Bayer's multibillion-dollar settlements over its weedkiller Roundup, herbicide dicamba and allegations over waterway contamination, as well as a $186 million verdict in favor of consumers who claimed that Johnson & Johnson talc products caused their cancer made Law360's list of the top product liability cases so far this year.

  3. July 28, 2020

    6th Circ. Questions Opioid Negotiation Class 'Inventiveness'

    A Sixth Circuit judge on Tuesday questioned whether a novel negotiation class aimed at resolving the opioid multidistrict litigation was needed, given that there are already mechanisms for litigating and settling class actions.

  4. July 27, 2020

    Opioid MDL Judge Won't Set Up $3B Fund For Plaintiffs' Attys

    An Ohio federal judge refused Monday to set up a $3 billion "common benefit fund" to cover fees incurred by attorneys for the plaintiffs in sprawling multidistrict opioid litigation, saying that now's not the time for a "one-size-fits-all" approach given a possible national settlement.

  5. July 20, 2020

    Opioid Judge 'Concerned' About Amerisource Hiding Docs

    An Ohio federal judge on Monday ordered AmerisourceBergen Drug Corp. to reevaluate why it hasn't produced key documents in opioid multidistrict litigation, saying Monday that he is "concerned" by new omissions and frequent changes in privilege designations. 

  6. July 17, 2020

    Product Liability Cases To Watch In 2020: Midyear Review

    Among upcoming product liability cases in the rest of 2020 are oral arguments this fall before the U.S. Supreme Court involving jurisdiction questions in automaker Ford's challenges to a pair of defect suits, as well as an expected rise in suits related to COVID-19 claims. Here are Law360's cases to watch for the rest of the year.

  7. July 16, 2020

    6th Circ. Again Refuses To Boot Judge From Opioid MDL

    The Sixth Circuit on Thursday shot down a second bid to disqualify an Ohio federal judge from overseeing the opioid multidistrict litigation after CVS Pharmacy Inc. and other national pharmacy chains accused him of blatant bias.

  8. July 13, 2020

    'Unfounded Attacks' On Opioid Judge Must Fail, 6th Circ. Told

    CVS Pharmacy Inc., Walgreen Co. and other national pharmacy chains are making phony bias allegations against the Ohio federal judge overseeing multidistrict opioid litigation because they're upset about having lost several legal arguments, local governments have told the Sixth Circuit.

  9. July 07, 2020

    Bias Charge Is 'Dangerous Fiction,' Opioid MDL Judge Says

    The Ohio federal judge overseeing multidistrict opioid litigation lambasted Walgreen Co., CVS Health Corp. and other pharmacy giants Tuesday for seeking his disqualification from the sprawling MDL, telling the Sixth Circuit that allegations of bias are reckless and untrue.

  10. July 07, 2020

    Amerisource Tries To Save CEO From Opioid Bellwether Depo

    AmerisourceBergen Drug Corp. has urged a West Virginia federal judge to undo a special master's order that its CEO testify in the second bellwether opioid suit expected to head to trial in federal multidistrict litigation, arguing that the ruling opens the floodgates to "limitless" depositions of the executive.